Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Recovery of a protein-rich biomass from shrimp (Pandalus borealis) boiling water: A colloidal study.

Forghani B, Bordes R, Ström A, Undeland I.

Food Chem. 2019 Jul 30;302:125299. doi: 10.1016/j.foodchem.2019.125299. [Epub ahead of print]

PMID:
31437710
2.

Dual-Energy CT Texture Analysis With Machine Learning for the Evaluation and Characterization of Cervical Lymphadenopathy.

Seidler M, Forghani B, Reinhold C, Pérez-Lara A, Romero-Sanchez G, Muthukrishnan N, Wichmann JL, Melki G, Yu E, Forghani R.

Comput Struct Biotechnol J. 2019 Jul 16;17:1009-1015. doi: 10.1016/j.csbj.2019.07.004. eCollection 2019.

3.

Radiomics and Artificial Intelligence for Biomarker and Prediction Model Development in Oncology.

Forghani R, Savadjiev P, Chatterjee A, Muthukrishnan N, Reinhold C, Forghani B.

Comput Struct Biotechnol J. 2019 Jul 12;17:995-1008. doi: 10.1016/j.csbj.2019.07.001. eCollection 2019. Review.

4.

Head and neck squamous cell carcinoma: prediction of cervical lymph node metastasis by dual-energy CT texture analysis with machine learning.

Forghani R, Chatterjee A, Reinhold C, Pérez-Lara A, Romero-Sanchez G, Ueno Y, Bayat M, Alexander JWM, Kadi L, Chankowsky J, Seuntjens J, Forghani B.

Eur Radiol. 2019 Apr 12. doi: 10.1007/s00330-019-06159-y. [Epub ahead of print]

PMID:
30980127
5.

Spectral multi-energy CT texture analysis with machine learning for tissue classification: an investigation using classification of benign parotid tumours as a testing paradigm.

Al Ajmi E, Forghani B, Reinhold C, Bayat M, Forghani R.

Eur Radiol. 2018 Jun;28(6):2604-2611. doi: 10.1007/s00330-017-5214-0. Epub 2018 Jan 2.

PMID:
29294157
6.

Advanced Tissue Characterization and Texture Analysis Using Dual-Energy Computed Tomography: Horizons and Emerging Applications.

Forghani R, Srinivasan A, Forghani B.

Neuroimaging Clin N Am. 2017 Aug;27(3):533-546. doi: 10.1016/j.nic.2017.04.007. Epub 2017 Jun 7. Review.

PMID:
28711211
7.

Endometrial Carcinoma: MR Imaging-based Texture Model for Preoperative Risk Stratification-A Preliminary Analysis.

Ueno Y, Forghani B, Forghani R, Dohan A, Zeng XZ, Chamming's F, Arseneau J, Fu L, Gilbert L, Gallix B, Reinhold C.

Radiology. 2017 Sep;284(3):748-757. doi: 10.1148/radiol.2017161950. Epub 2017 May 10.

PMID:
28493790
8.

Enzyme Hydrolysates from Stichopus horrens as a New Source for Angiotensin-Converting Enzyme Inhibitory Peptides.

Forghani B, Ebrahimpour A, Bakar J, Abdul Hamid A, Hassan Z, Saari N.

Evid Based Complement Alternat Med. 2012;2012:236384. doi: 10.1155/2012/236384. Epub 2012 Aug 15.

9.

A glutamic acid-producing lactic acid bacteria isolated from Malaysian fermented foods.

Zareian M, Ebrahimpour A, Bakar FA, Mohamed AK, Forghani B, Ab-Kadir MS, Saari N.

Int J Mol Sci. 2012;13(5):5482-97. doi: 10.3390/ijms13055482. Epub 2012 May 7.

10.

Purification, characterization and thermal inactivation kinetics of a non-regioselective thermostable lipase from a genotypically identified extremophilic Bacillus subtilis NS 8.

Olusesan AT, Azura LK, Forghani B, Bakar FA, Mohamed AK, Radu S, Manap MY, Saari N.

N Biotechnol. 2011 Oct;28(6):738-45. doi: 10.1016/j.nbt.2011.01.002. Epub 2011 Jan 14.

PMID:
21238617
11.

High throughput quantitative colorimetric microneutralization assay for the confirmation and differentiation of West Nile Virus and St. Louis encephalitis virus.

Taketa-Graham M, Powell Pereira JL, Baylis E, Cossen C, Oceguera L, Patiris P, Chiles R, Hanson CV, Forghani B.

Am J Trop Med Hyg. 2010 Mar;82(3):501-4. doi: 10.4269/ajtmh.2010.09-0297. Erratum in: Am J Trop Med Hyg. 2010 Dec;83(6):1356. Forghani, BagHer [corrected to Forghani, Bagher].

12.

Effect of fenugreek seeds on blood glucose and lipid profiles in type 2 diabetic patients.

Kassaian N, Azadbakht L, Forghani B, Amini M.

Int J Vitam Nutr Res. 2009 Jan;79(1):34-9. doi: 10.1024/0300-9831.79.1.34.

PMID:
19839001
13.

Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine.

LeBaron CW, Forghani B, Matter L, Reef SE, Beck C, Bi D, Cossen C, Sullivan BJ.

J Infect Dis. 2009 Sep 15;200(6):888-99. doi: 10.1086/605410.

PMID:
19659440
14.

Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine.

LeBaron CW, Forghani B, Beck C, Brown C, Bi D, Cossen C, Sullivan BJ.

J Infect Dis. 2009 Feb 15;199(4):552-60. doi: 10.1086/596207.

PMID:
19113988
15.

The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features.

Nagel MA, Cohrs RJ, Mahalingam R, Wellish MC, Forghani B, Schiller A, Safdieh JE, Kamenkovich E, Ostrow LW, Levy M, Greenberg B, Russman AN, Katzan I, Gardner CJ, Häusler M, Nau R, Saraya T, Wada H, Goto H, de Martino M, Ueno M, Brown WD, Terborg C, Gilden DH.

Neurology. 2008 Mar 11;70(11):853-60. doi: 10.1212/01.wnl.0000304747.38502.e8. Review.

16.

Seroprevalence of measles antibody in the US population, 1999-2004.

McQuillan GM, Kruszon-Moran D, Hyde TB, Forghani B, Bellini W, Dayan GH.

J Infect Dis. 2007 Nov 15;196(10):1459-64. Epub 2007 Nov 1.

PMID:
18008224
17.

Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment.

LeBaron CW, Beeler J, Sullivan BJ, Forghani B, Bi D, Beck C, Audet S, Gargiullo P.

Arch Pediatr Adolesc Med. 2007 Mar;161(3):294-301.

PMID:
17339511
18.

The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy.

Nagel MA, Forghani B, Mahalingam R, Wellish MC, Cohrs RJ, Russman AN, Katzan I, Lin R, Gardner CJ, Gilden DH.

Neurology. 2007 Mar 27;68(13):1069-73. Epub 2007 Feb 7.

PMID:
17287447
19.

Beyond viruses: clinical profiles and etiologies associated with encephalitis.

Glaser CA, Honarmand S, Anderson LJ, Schnurr DP, Forghani B, Cossen CK, Schuster FL, Christie LJ, Tureen JH.

Clin Infect Dis. 2006 Dec 15;43(12):1565-77. Epub 2006 Nov 8.

PMID:
17109290
20.

Rubella immunity levels in the United States population: has the threshold of viral elimination been reached?

Hyde TB, Kruszon-Moran D, McQuillan GM, Cossen C, Forghani B, Reef SE.

Clin Infect Dis. 2006 Nov 1;43 Suppl 3:S146-50. Erratum in: Clin Infect Dis. 2008 Mar 15;46(6):962.

PMID:
16998774
21.
22.

Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with encephalitis.

Isaacson E, Glaser CA, Forghani B, Amad Z, Wallace M, Armstrong RW, Exner MM, Schmid S.

Clin Infect Dis. 2005 Mar 15;40(6):890-3. Epub 2005 Feb 21.

PMID:
15736026
23.

MRI abnormalities in chronic active varicella zoster infection.

Blumenthal DT, Salzman KL, Baringer JR, Forghani B, Gilden DH.

Neurology. 2004 Oct 26;63(8):1538-9. No abstract available.

PMID:
15505191
24.

Kaposi's sarcoma-associated herpesvirus glycoprotein K8.1 is dispensable for virus entry.

Luna RE, Zhou F, Baghian A, Chouljenko V, Forghani B, Gao SJ, Kousoulas KG.

J Virol. 2004 Jun;78(12):6389-98.

25.

Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.

Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE.

J Infect Dis. 2004 May 1;189 Suppl 1:S116-22.

PMID:
15106100
26.

Acyclovir responsive brain stem disease after the Ramsay Hunt syndrome.

Hu S, Walker M, Czartoski T, Cheng A, Forghani B, Gilden DH, Garden GA.

J Neurol Sci. 2004 Jan 15;217(1):111-3.

PMID:
14675618
27.

Stress-induced subclinical reactivation of varicella zoster virus in astronauts.

Mehta SK, Cohrs RJ, Forghani B, Zerbe G, Gilden DH, Pierson DL.

J Med Virol. 2004 Jan;72(1):174-9.

PMID:
14635028
28.

Multifocal varicella-zoster virus vasculopathy without rash.

Russman AN, Lederman RJ, Calabrese LH, Embi PJ, Forghani B, Gilden DH.

Arch Neurol. 2003 Nov;60(11):1607-9.

PMID:
14623735
29.

Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors.

Pellett PE, Wright DJ, Engels EA, Ablashi DV, Dollard SC, Forghani B, Glynn SA, Goedert JJ, Jenkins FJ, Lee TH, Neipel F, Todd DS, Whitby D, Nemo GJ, Busch MP; Retrovirus Epidemiology Donor Study.

Transfusion. 2003 Sep;43(9):1260-8.

PMID:
12919429
30.

Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life.

Gans H, DeHovitz R, Forghani B, Beeler J, Maldonado Y, Arvin AM.

Vaccine. 2003 Jul 28;21(24):3398-405. Review.

PMID:
12850348
31.

Chronic active VZV infection manifesting as zoster sine herpete, zoster paresis and myelopathy.

Morita Y, Osaki Y, Doi Y, Forghani B, Gilden DH.

J Neurol Sci. 2003 Aug 15;212(1-2):7-9.

PMID:
12809993
32.

Varicella in Americans from NHANES III: implications for control through routine immunization.

Kilgore PE, Kruszon-Moran D, Seward JF, Jumaan A, Van Loon FP, Forghani B, McQuillan GM, Wharton M, Fehrs LJ, Cossen CK, Hadler SC.

J Med Virol. 2003;70 Suppl 1:S111-8.

PMID:
12627498
33.

In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000.

Glaser CA, Gilliam S, Schnurr D, Forghani B, Honarmand S, Khetsuriani N, Fischer M, Cossen CK, Anderson LJ; California Encephalitis Project, 1998-2000.

Clin Infect Dis. 2003 Mar 15;36(6):731-42. Epub 2003 Mar 3.

PMID:
12627357
34.

The protean manifestations of varicella-zoster virus vasculopathy.

Gilden DH, Mahalingam R, Cohrs RJ, Kleinschmidt-DeMasters BK, Forghani B.

J Neurovirol. 2002 Dec;8 Suppl 2:75-9. Review.

PMID:
12491155
35.

Two patients with unusual forms of varicella-zoster virus vasculopathy.

Gilden DH, Lipton HL, Wolf JS, Akenbrandt W, Smith JE, Mahalingam R, Forghani B.

N Engl J Med. 2002 Nov 7;347(19):1500-3. No abstract available.

36.

Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result.

Weil AA, Glaser CA, Amad Z, Forghani B.

Clin Infect Dis. 2002 Apr 15;34(8):1154-7. Epub 2002 Mar 21.

PMID:
11915008
37.

Epstein-Barr virus myeloradiculitis and encephalomyeloradiculitis.

Majid A, Galetta SL, Sweeney CJ, Robinson C, Mahalingam R, Smith J, Forghani B, Gilden DH.

Brain. 2002 Jan;125(Pt 1):159-65.

PMID:
11834601
38.

Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic.

Osmond DH, Buchbinder S, Cheng A, Graves A, Vittinghoff E, Cossen CK, Forghani B, Martin JN.

JAMA. 2002 Jan 9;287(2):221-5.

PMID:
11779265
39.

Rubella seropositivity in the United States, 1988-1994.

Dykewicz CA, Kruszon-Moran D, McQuillan GM, Williams WW, Van Loon FP, Cossen C, Forghani B, Hadler SC.

Clin Infect Dis. 2001 Oct 15;33(8):1279-86. Epub 2001 Sep 20.

PMID:
11565065
40.

Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months.

Gans H, Yasukawa L, Rinki M, DeHovitz R, Forghani B, Beeler J, Audet S, Maldonado Y, Arvin AM.

J Infect Dis. 2001 Oct 1;184(7):817-26. Epub 2001 Aug 22.

PMID:
11528592
41.

Acute, chronic, and recurrent varicella zoster virus neuropathy without zoster rash.

Fox RJ, Galetta SL, Mahalingam R, Wellish M, Forghani B, Gilden DH.

Neurology. 2001 Jul 24;57(2):351-4.

PMID:
11468330
42.

Nucleotide sequence analysis of varicella-zoster virus glycoprotein E epitope coding regions.

Shankar V, Fisher S, Forghani B, Vafai A.

Vaccine. 2001 Jul 16;19(28-29):3830-3.

PMID:
11427254
43.

Three-dimensional structure of the human herpesvirus 8 capsid.

Wu L, Lo P, Yu X, Stoops JK, Forghani B, Zhou ZH.

J Virol. 2000 Oct;74(20):9646-54.

44.
45.

Stability of a varicella-zoster virus glycoprotein E epitope.

Vafai A, Forghani B, Kilpatrick D, Ling J, Shankar V.

Arch Virol. 2000;145(1):85-97.

PMID:
10664408
46.

Use of epidemiologically well-defined subjects and existing immunofluorescence assays to calibrate a new enzyme immunoassay for human herpesvirus 8 antibodies.

Martin JN, Amad Z, Cossen C, Lam PK, Kedes DH, Page-Shafer KA, Osmond DH, Forghani B.

J Clin Microbiol. 2000 Feb;38(2):696-701.

47.
48.
49.
50.

Molluscum contagiosum virus grows in human skin xenografts.

Paslin D, Krowka J, Forghani B.

Arch Dermatol Res. 1997 Jul;289(8):486-8. No abstract available.

PMID:
9266028

Supplemental Content

Loading ...
Support Center